Toll-like receptors 2 and 6 mediate apoptosis and inflammation in ischemic skeletal myotubes

Area of Science:

• Molecular Biology
• Immunology
• Pathophysiology

Background:

• Critical limb ischemia (CLI) is characterized by skeletal muscle damage, but its underlying mechanisms remain unclear.
• Toll-like receptors (TLRs) are implicated in ischemia-induced tissue injury, yet their specific role in CLI-related skeletal muscle damage is not well-defined.

Purpose of the Study:

• To investigate the expression and role of Toll-like receptors (TLR) 2 and 6 in skeletal muscle damage associated with critical limb ischemia (CLI).

Main Methods:

• Analysis of TLR2 and TLR6 expression in skeletal muscle from CLI patients.
• In vitro experiments using myotubes subjected to ischemia to assess TLR expression and signaling.
• Evaluation of downstream inflammatory cytokine (interleukin-6) secretion and muscle apoptosis.
• Assessment of the effects of TLR2 and TLR6 neutralizing antibodies on these processes.

Main Results:

• Toll-like receptor (TLR) 2 and TLR6 expression were found to be elevated in the skeletal muscle of patients with CLI.
• Ischemia induced upregulation of TLR2 and TLR6 in myotubes, activating the downstream TLR signaling pathway.
• Activation of the TLR pathway resulted in increased interleukin-6 secretion and muscle apoptosis, effects that were blocked by TLR2 and TLR6 neutralizing antibodies.

Conclusions:

• Toll-like receptors (TLR) 2 and 6 are upregulated in ischemic skeletal muscle during critical limb ischemia (CLI).
• These TLRs play a significant role in mediating ischemia-induced muscle damage, including inflammation and apoptosis.
• Targeting the TLR pathway locally presents a potential therapeutic strategy for managing CLI-associated skeletal muscle injury.